Bone Marrow TransplantationTransplantation, HomologousBone MarrowGraft vs Host DiseaseBone Marrow CellsWhole-Body IrradiationLeukemiaAnemia, AplasticTransplantation ConditioningTissue DonorsTransplantation ChimeraTransplantation, AutologousBone and BonesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytomegalovirus InfectionsGraft SurvivalHematopoietic Stem Cell TransplantationHematologic NeoplasmsLeukemia, Myeloid, AcuteRecurrenceLymphocyte DepletionImmunosuppressive AgentsHistocompatibility TestingBusulfanPrecursor Cell Lymphoblastic Leukemia-LymphomaHistocompatibilityTime FactorsHematopoietic Stem CellsNuclear FamilyLymphocyte TransfusionCombined Modality TherapyAcute DiseaseRemission InductionBone Marrow PurgingRadiation ChimeraCyclosporineTreatment OutcomeTransplantation, IsogeneicCyclophosphamideMice, Inbred C57BLT-LymphocytesGraft vs Host ReactionSurvival AnalysisLeukocyte TransfusionImmunosuppressionBone Marrow DiseasesHematopoiesisRetrospective StudiesGraft RejectionCytomegalovirusGraft vs Tumor EffectLeukemia, MyeloidHepatic Veno-Occlusive DiseaseBone Marrow ExaminationBone RemodelingKidney TransplantationMyelodysplastic SyndromesChimeraBone Marrow NeoplasmsHLA AntigensLiver TransplantationHematologic DiseasesTransplantation ImmunologyGraft vs Leukemia EffectMice, Inbred BALB CLymphoma, Non-HodgkinFatal OutcomeColony-Forming Units AssayImmunocompromised HostSurvival RateActuarial AnalysisOpportunistic InfectionsSevere Combined ImmunodeficiencyFlow CytometryBone DensityFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsSpleenDisease-Free SurvivalStem Cell TransplantationCell DifferentiationLeukocyte CountGanciclovirPneumonia, ViralGranulocyte Colony-Stimulating FactorBone ResorptionPrognosisHeart TransplantationCells, CulturedMultiple MyelomaAntilymphocyte SerumInfectionPancytopeniaPolymerase Chain ReactionAntibodies, MonoclonalMethotrexateLymphomaAntigens, CD34CytarabineBone Neoplasms